Document Detail

Modulation of serum gastric parietal cell antibody level by levamisole and vitamin B12 in oral lichen planus.
MedLine Citation:
PMID:  20659263     Owner:  NLM     Status:  In-Process    
OBJECTIVES: The objective of this study was to test the efficacy of three different treatment modalities on the reduction of serum anti-gastric parietal cell autoantibody (GPCA) level in GPCA-positive oral lichen planus (OLP) patients.
MATERIALS AND METHODS: Of 147 GPCA-positive OLP patients, 100 were treated with levamisole plus vitamin B12, 10 with vitamin B12 only and 37 with levamisole only. The serum GPCA levels in 147 OLP patients were measured at baseline and after treatment.
RESULTS: Treatment with levamisole plus vitamin B12 for a period of 2-50 months and treatment with vitamin B12 only for a period of 4-44 months could effectively reduce the high serum GPCA level to undetectable level in 100 and 10 OLP patients, respectively. However, treatment with levamisole only for a period of 2-50 months could not modulate the high mean serum GPCA titer to a significantly lower level in 37 OLP patients. A 92% GPCA recurrence rate was found in 25 OLP patients receiving no further vitamin B12 treatment during the GPCA-negative remission period.
CONCLUSION: For GPCA-positive OLP patients, treatment modality containing vitamin B12 can effectively reduce the high serum GPCA level to undetectable level. OLP patients with underlying autoimmune atrophic gastritis trait should receive a maintenance vitamin B12 treatment for life.
H-P Lin; Y-P Wang; J-S Chia; C-P Chiang; A Sun
Related Documents :
19765253 - Does cinacalcet improve the prognosis of dialysis patients?
9604983 - Use of a rapid intraoperative parathyroid hormone assay in the surgical management of p...
23821383 - β-amyloid deposits in veins in patients with cerebral amyloid angiopathy and intracere...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Oral diseases     Volume:  17     ISSN:  1601-0825     ISO Abbreviation:  Oral Dis     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2010-12-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9508565     Medline TA:  Oral Dis     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  95-101     Citation Subset:  D    
Copyright Information:
© 2010 John Wiley & Sons A/S.
Graduate Institute of Clinical Dentistry, School of Dentistry, National Taiwan University, Taipei.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prevalence and risk indicators of oral mucosal lesions in an urban population from South Brazil.
Next Document:  Apoptotic effect of Polygonum Cuspidatum in oral cancer cells through the regulation of specificity ...